Johns Hopkins HIV Guide
Famciclovir
INDICATIONS
FDA
FDA
- Recurrent genital herpes (suppression and treatment) in immunocompetent and HIV+ pts.
- Treatment of herpes zoster.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: April 28, 2018
Citation
Dzintars, Kathryn. "Famciclovir." Johns Hopkins HIV Guide, 2018. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545071/all/Famciclovir.
Dzintars K. Famciclovir. Johns Hopkins HIV Guide. 2018. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545071/all/Famciclovir. Accessed September 27, 2023.
Dzintars, K. (2018). Famciclovir. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545071/all/Famciclovir
Dzintars K. Famciclovir [Internet]. In: Johns Hopkins HIV Guide. ; 2018. [cited 2023 September 27]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545071/all/Famciclovir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Famciclovir
ID - 545071
A1 - Dzintars,Kathryn,Pharm.D., BCPS
Y1 - 2018/04/28/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545071/all/Famciclovir
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
